Five years into the COVID-19 pandemic, many people still have questions. Here's what doctors said they're hearing – and what ...
Jay Bhattacharya, a vocal critic of Covid lockdowns, is set to become NIH director under Trump, signalling a major shift in US public health policy.
Our fair value estimate for SJM is HKD 4.5 per share, which implies enterprise value/EBITDA of 13 times in 2025. We think the opening of SJM’s Cotai property, Grand Lisboa Palace, provides a ...
Public health experts are urging the government to protect people from Long Covid, which they say could have already affected ...